WO2002080864A1 - Novel nanoemulsions - Google Patents

Novel nanoemulsions Download PDF

Info

Publication number
WO2002080864A1
WO2002080864A1 PCT/US2002/009630 US0209630W WO02080864A1 WO 2002080864 A1 WO2002080864 A1 WO 2002080864A1 US 0209630 W US0209630 W US 0209630W WO 02080864 A1 WO02080864 A1 WO 02080864A1
Authority
WO
WIPO (PCT)
Prior art keywords
surfactant
nanoemulsion
group
salts
surfactants
Prior art date
Application number
PCT/US2002/009630
Other languages
French (fr)
Inventor
Liliana George
Charles C. Tadlock
Peter J. Tsolis
Raffi J. Balian
Original Assignee
Color Access, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Color Access, Inc. filed Critical Color Access, Inc.
Priority to US10/471,044 priority Critical patent/US20040115159A1/en
Priority to EP02728600A priority patent/EP1377255A4/en
Priority to AU2002258644A priority patent/AU2002258644B2/en
Priority to JP2002578903A priority patent/JP4444565B2/en
Priority to CA002442660A priority patent/CA2442660A1/en
Publication of WO2002080864A1 publication Critical patent/WO2002080864A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/362Polycarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21Emulsions characterized by droplet sizes below 1 micron
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm

Definitions

  • the invention relates to cosmetic and pharmaceutical formulations. More specifically, the invention relates to nanoemulsions which may be transparent or translucent, and contain low levels of emulsifiers.
  • Transparent emulsions can be prepared in the form of microemulsions, in which the dispersed phase is essentially solubihzed in the continuous phase by the action of a surfactant, and often, a cosurfactant. Rather than discrete isolated dispersed phase droplets, micelles comprising an inner core of the disperse phase material surrounded by a layer of surfactant are formed These systems upon formation are normally clear, forming very small micellar droplets, but ordinarily require fairly large quantities of surfactant. Normally, it is desirable to keep surfactant levels low in cosmetic compositions, however, because they can strip the skin of its natural hpid barrier, and thus leave the skin more susceptible to irritants.
  • a nanoemulsion is defined as an oil-m-water emulsion in which the size of the dispersed oil droplets is less than 100 nm.
  • Nanoemulsions provide an elegant, translucent or transparent vehicle that can be used for a variety of different product types.
  • the nanoemulsion is a system in very delicate balance, subject to disruption if the wrong component is added, and not ordinarily capable of taking on too much oil.
  • the known nanoemulsion systems may rely on the presence of relatively high levels of emulsifiers that are considered irritating, such as ethoxylated fatty ethers and esters.
  • a truly desirable nanoemulsion should retain its transparency or translucency, be able to accommodate a reasonable amount of additives, such as fragrance or actives, while remaining stable, and utilize a low level of non-imtatmg emulsifiers, so as to remain mild and gentle on the skin of the user.
  • the present invention provides such a nanoemulsion.
  • the present invention relates to stable oil-in-water nanoemulsions comprising as its principle emulsifier a ternary system of surfactants comprising a cationic, anionic and bridging surfactant.
  • the system is believed to provide a unique complex which, even when used at low levels, in combination with standard emulsion components, yields an attractive, translucent or transparent product that has a variety of possible uses.
  • the components of the ternary system are used in a molar ratio of approximately 1: >1: ⁇ 1 anionic: bridging: cationic, preferably with a range of up from about 1 : 1 :0.1 up to about 1 :3: 1, and also preferably with an overall approximately neutral charge.
  • the oil- in- water nanoemulsions of the invention are prepared in much the same way as are other nanoemulsions.
  • the aqueous phase may be any cosmetically acceptable water based material, such as deionized water, or a floral water.
  • the oil phase may be any cosmetically or pharmaceutically acceptable oil, such an oil being defined for the present purpose as any pharmaceutically or cosmetically acceptable material which is substantially insoluble in water.
  • the oils can perform different functions in the composition, the specific choice is dependent on the purpose for which it is intended.
  • the oils may be volatile or non-volatile, or a mixture of both.
  • suitable volatile oils include, but are not limited to, both cyclic and linear sihcones, such as octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane; or straight or branched chain hydrocarbons having from 8-20 carbon atoms, such as decane, dodecane, tridecane, tetradecane, and C8-20 isoparaffins.
  • Non-volatile oils include, but are not limited to, vegetable oils, such as coconut oil, jojoba oil, sunflower oil, palm oil, soybean oil; carboxylic acid esters such as isostearyl neopentanoate, cetyl octanoate, cetyl ⁇ cinoleate, octyl palmitate, dioctyl malate, coco-dicaprylate/caprate, decyl isostearate, my ⁇ styl my ⁇ state; animal oils such as lanolm and lanolin derivatives, tallow, mink oil or cholesterol; glyceryl esters, such as glyceryl stearate, glyceryl dioleate, glyceryl distearate, glyceryl lmoleate, glyceryl my ⁇ state; non-volatile sihcones, such as dimethicone, dimethiconol, dimethicone copolyol, phenyl trim
  • Water ordinarily will constitute from about 40-70% of the total emulsion, preferably about 50- 65%, while the oil is ordinarily about 5-30% and preferably about 10-20% of the emulsion as a whole
  • the ternary surfactant used is ordinarily added to the phase in which it is most compatible, using heat if necessary to accomplish better solubility or dispersibility, along with any active components which may be desired in the emulsion, and all components mixed together at low pressure.
  • the mixture is then subjected to high pressure mixing.
  • high pressure in the present context is meant a pressure of at least about 10,000 psi to about 20,000 psi; preferably about 11-17,000 psi.
  • the emulsion is subjected to at least two passes, more preferably at least three passes under high pressure. There is no upper limit to the number of passes, but there appears to be no major improvement to be achieved after about seven passes.
  • the preferred equipment is a microfluidizer, such as is available from Microfluidics. However, other suitable high pressure equipment is sold under the brand names Niro Soavi and Rannie.
  • the particle size distribution is normally narrow, and very small, less than lOOnm, preferably with an average size of about 30-50 nm.
  • a crucial element of the nanoemulsion is the ternary surfactant system used to emulsify the nanoemulsion.
  • the system comprises three essential elements, namely at least one anionic surfactant, at least one cationic surfactant and at least one bridging surfactant.
  • Systems of this type are available commercially as premade blends from Stepan Company, Northfield Illinois, identified as their C-A-N technology.
  • the component surfactants can be added to the emulsion separately, but more often will be preblended before addition.
  • cationic or anionic surfactants are pharmaceutically or cosmetically acceptable surfactants.
  • examples of such surfactants can be readily found, among other sources, in McCutcheon's Detergents and Emulsifiers, M.C. Publishing Company, North American Edition, 2000.
  • the cationic surfactant can be selected from among fatty amine salts, fatty diamine salts, polyamme salts, quaternary ammonium salts, or polyoxyethylenated fatty amine salts, or combinations thereof, with anions being selected from, among others, halogen, sulfate, methosulfate, ethosulfate, tosylate, acetate, phosphate, nitrate, sulfonate, and carboxylate.
  • the quaternary ammonium salts include mono-long chain alkyl-tri-short chain alkyl ammonium hahdes, wherein the long chain alkyl group has from about 8 to about 22 carbon atoms, and is derived from long chain fatty acids, and the short chain alkyl groups can be the same or different but preferably independently ethyl or methyl.
  • useful quaternary surfactants include, but are not limited to, cetyl trimethyl ammonium chloride, lauryl t ⁇ methyl ammonium chloride, cocamidopropyl PG-dimonium chloride phosphate, cet ⁇ monium bromide, cet ⁇ monium chloride, hydroxycetyl hydroxyethyl dimonium chloride, quaternium 52, PPG- 40 diethylmomum chloride, dicocodimomum chloride, behentrimonium chloride, quatern ⁇ um-26, quatern ⁇ um-60, isostearyl ethylimidazolmium ethosulfate, and dihydroxypropyl PEG-5 hneoleammonium chloride.
  • Useful salts of primary, secondary, and tertiary fatty amines include those having substituted or unsubstituted alkyl groups having from about 12 to about 22 carbon atoms.
  • Suitable salts include the halogen, acetate, phosphate, nitrate, citrate, lactate, and alkyl sulfate salts.
  • Amine salts derived from amine such as stearamido propyl dimethyl amine, diethyl ammo ethyl stearamide, dimethyl stearamine, dimethyl soyamine, soyamine, my ⁇ styl amine, tridecyl amine, ethyl stearylamme, N- tallow propane diamine, dihydroxy ethyl stearylamme, and arachidylbehenylamine, stearylamme hydrogen chloride, soyamine chloride, stearylamme formate, N-tallow propane diamine dichlonde and stearamidopropyl dimethylamine citrate
  • amine salt compounds include lmidazohnes, lmadazolmiums and py ⁇ dmiums, wherein the compound has at least one nonionic hydrophile containing radical, such as 2-heptadecyl-4.5-d ⁇ hydro- 1 H-
  • Anionic surfactants used in the present system are not limited in their nature, again however, preferably being pharmaceutically or cosmetically acceptable.
  • the anionic surfactants include, but are not limited to, sulfates, such as linear and branched primary and secondary alkyl sulfates, alkyl ethoxysulfates, alkyl ether sulfates, fatty oleyl glycerol sulfates, alkyl phenol ethyoxylated sulfates, alkyl phenol ethylene oxide ether sulfates, C5-C17 acyl-N-(Cl-C4 alkyl) and -N-(C1-C2 hydroxyalkyl)glucam ⁇ ne sulfates, and sulfates of alkylpolysaccha ⁇ des such as the sulfates of alkyl polyglucoside.; sulfonates such as salts of C5-C20 linear alkylbenzene
  • anionic surfactant is the material known as surfactm, a naturally occurring product produced by fermentation of certain strains of Bacillus subtihs, and is commercially available from Showa Denko, KK, Japan.
  • Preferred anionic surfactants, particularly for cosmetic purposes are alkylaryl sulfonates, alkylaryl sulfonic acids, carboxylated alcohols, carboxylic acids, diphenyl sulfonate derivatives, ethoxylated fatty acids, fluorocarbon-based surfactants, lsethionates, hgnm and derivatives, olefin sulfonates, phosphate esters, phosphorus organic derivatives, polysaccha ⁇ des, acrylic acids, and acrylamides, protein based surfactants, sarcosme, sulfates and sulfomcs of oils and fatty esters, sulfates and sulfomcs of ethoxylated alkylphenol
  • the bridging surfactants used in the present invention include semi-polar nonionic surfactants, ethoxamide surfactants, and amphoteric surfactants.
  • Semi-polar nonionic surfactants include, but are not limited to, water soluble amine oxides, and water soluble sulfoxides, having at least one CIO- 18 alkyl moiety, and at least one moiety selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1-3 carbon atoms, or amine- oxide derived surfactants.
  • Ethoxamides useful in the invention are ethoxylated alkanol amides or polyethylene glycol amides such as PEG-3 cocoamide or PEG-6 lauramide.
  • the bridging surfactant is an amphoteric surfactant.
  • Example of useful amphote ⁇ cs include, but are not limited to, alkyl glycinates, propionates, lmidazolmes, amphoalkylsulfonates, N-alkylammopropionic acids, N- alkylimmodipropionic acids, lmidazohne carboxylates, N-alkybetaines, amido propyl betames, sarcosmates, cocoamphocarboxyglycinates, amine oxides, sulfobetaines, or sultames.
  • Particularly preferred, especially for cosmetic use are the betame amphoteric surfactants, particularly amidopropyl betames.
  • the choice of components for the system is preferably based on a total HLB for the system of about 5-12, and preferably an overall substantially neutral charge.
  • the preferred combination of surfactants for cosmetic use is a glutamate as anionic surfactant, a quaternary ammonium salt as cationic surfactant, and an amidopropyl betaine as amphoteric. This combination is especially mild when applied to the skin and hair.
  • the ternary system is, in many embodiments, preferably used in a molar ratio of approximately 1 anionic: >1 bridging: 1 cationic.
  • the proportion of cationic surfactant can be reduced to ⁇ 1, in a range down to a level of about 0.1 up to less than 1, preferably in a range of from about 0.25 to about 0.5.
  • the ternary combination in the stated molar ratios, will be added to the composition in an amount ranging from about 0.5-5 % total surfactant, preferably 1-3% total surfactant, by weight of the total composition.
  • the combination will be added as a preblend, but each component can also be added separately to the composition.
  • each component is itself recognized as a surfactant, none of the components alone is adequate to achieve a stable nanoemulsion, all three must be used together.
  • the ternary system can be used alone, it is sometimes desirable to supplement the three main components with an additional small quantity of a secondary surfactant, preferably with an HLB of between about 3-5.
  • the secondary surfactant is a glyceryl fatty ester and derivatives thereof, such as glyceryl monostearate, glyceryl monolaurate, glyceryl monooleate, PEG 100 stearate, glycerol mono/distearate, polyglyceryl-2-stearate, fatty acid polyglycerol esters, hexaglycerol distearate, propylene glycol monolaurate and propylene glycol stearate.
  • secondary surfactants include hydroxylated lanolin, lanolin alcohol, ethoxylated castor oil, sorbitan monotallate, sorbitan monooleate, sorbitan sesquioleate, ethoxylated fatty amines, lecithin, oleth-2, palmitic/stea ⁇ c acid esters, distilled monoglyce ⁇ des, block copolymers of ethylene oxide and propylene oxide, cholesterol, dimethicone copolyol, and ethoxylated triglyce ⁇ des, Normally, the secondary surfactant will be used in an amount of from about 0 5-5%, preferably about 0 5-2%, by weight of the total composition
  • alcohols for example, short chain monohydric alcohols, such as ethanol or isopropanol, and/or polyhyd ⁇ c alcohols, such as butylene or propylene glycol, isopentyl diol, or amido-diols.
  • a monohydric alcohol is strongly preferred, in an amount of from about greater than zero, to about 30%, preferably about 5-25%, and most preferred, at least about 10%, by weight of the composition.
  • Polyhyd ⁇ c alcohols if used, will be used in an amount of from about greater than zero to about 10%, preferably about 1-5%, by weight of the total composition.
  • compositions with active agents or additives appropriate to the intended use.
  • active agents or additives appropriate to the intended use.
  • the preferred use of the compositions are as pharmaceutical or cosmetic vehicles, for application to the skin or hair.
  • the nanoemulsions of the invention in part because of the presence of the cationic surfactant, provide a very efficient delivery system for a wide variety of active components.
  • the formulations are highly substantive to skin and hair, the emulsifying system exhibits a substantial degree of water resistance, and also potentially contributes to the preservation of the formulation as a whole .
  • additional components include, but are not limited to, agents for the eradication of age spots, keratoses and wrinkles, analgesics, anesthetics, anti-acne agents, antibacte ⁇ als, antiyeast agents, antifungal agents, antiviral agents, antidandruff agents, antidermatitis agents, antipru ⁇ tic agents, antiemetics, antimotion sickness agents, anti-inflammatory agents, antihyperkeratolytic agents, anti-dry skin agents, antiperspirants, antipsonatic agents, antiseborrheic agents, hair conditioners and hair treatment agents, antiaging agents, antiwrmkle agents, antiasthmatic agents and bronchodilators, sunscreen agents, antihistamine agents, skin lightening agents, depigmenting agents, vitamins, corticosteroids, self-tanning agents, hormones, retmoids such as retinoic acid and retinol, topical cardiovascular agents, clotnmazole, ketoconazole,
  • non-therapeutic or non-active agents such as emollients, flavors, colorants, fragrances, gellants, thickeners, sunscreens, and the like, which enhance the ultimate use of the product, particularly for topical cosmetic or pharmaceutical purposes, and provided care is taken to avoid choosing components that will interfere with the clarity of the product.
  • the final product can take the form of a milk, cream, lotion, gel, serum, or liquid spray, among others.
  • a particularly interesting use of the nanoemulsions of the invention is in the preparation of sunscreen formulations. It has been difficult to achieve a translucent product with the addition of sunscreens to other types of nanoemulsions.
  • the nanoemulsions of the invention may therefore incorporate one or more sunscreen agents, such as benzophenones, avobenzone, cmnamates, sahcylates, and the like.
  • a nanoemulsion of the following composition is prepared:
  • the components above are combined as follows: The water phase components (Phase I) are heated to 65°C, and the oil phase components (Phase II) are heated to 75°C When both phases have reached the proper temperature, the oil phase is added to the water phase under a Silverson homogenizer at about 5000-6000 rpm. This batch is then passed through a microfluidizer once, at a pressure of about 13,000-17,000 psi. The Phase III components are added under the Silverson homogenizer at about 5000-6000 rpm, and then the entire product is passed through a microfluidizer three more times. The resulting product is a translucent nanoemulsion which is stable for at least 4 weeks at 50°C.
  • Additional nanoemulsions are prepared using the following surfactant blends(all QS water to 100%):
  • a sunscreen-containing nanoemulsion is prepared as follows:
  • the formula described above is prepared as follows: The water phase and surfactant blend are heated to 65°C. The oil phase is heated to 75°C, and homogenized into the water. The mixture is passed through the microfluidizer once, and cooled to 30°C Phases III and IV are added in sequence, then phase V is added. The resulting mixture is then passed through the microfluidizer as described in Example 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

The invention provides oil-in-water nanoemulsions comprising as a primary surfactant a ternary system comprising at least one of each of an anionic surfactant, a bridging surfactant, and a cationic surfactant, preferably in a ratio of 1:≥1:≤1, with an overall substantially neutral charge. The nanoemulsions of the invention may be translucent or transparent, and provide a substantive and water-resistant vehicle for application of cosmetic, skin care or pharmaceutical products to skin and hair.

Description

NOVEL NANOEMULSIONS
Field of the Invention
The invention relates to cosmetic and pharmaceutical formulations. More specifically, the invention relates to nanoemulsions which may be transparent or translucent, and contain low levels of emulsifiers.
Background of the Invention
In recent years, the availability of clear personal care and cosmetic products has become increasingly important to the consumer. A clear product is perceived as light, clean, fresh and often cooling, features that can be important in certain types of products, for example, products for use in the sun, or makeup or skin care products to be used in warmer weather. The availability of such products, however, has frequently been limited to gels, soap-based sticks, and thin liquids. These forms, although obviously having their uses, are limited in the texture and feel that the final product can attain, and cannot approximate the classic cream or lotion feel conferred by standard oil-and-water emulsions. Achieving transparency, however, is not so easy when working from this type of base.
Transparent emulsions can be prepared in the form of microemulsions, in which the dispersed phase is essentially solubihzed in the continuous phase by the action of a surfactant, and often, a cosurfactant. Rather than discrete isolated dispersed phase droplets, micelles comprising an inner core of the disperse phase material surrounded by a layer of surfactant are formed These systems upon formation are normally clear, forming very small micellar droplets, but ordinarily require fairly large quantities of surfactant. Normally, it is desirable to keep surfactant levels low in cosmetic compositions, however, because they can strip the skin of its natural hpid barrier, and thus leave the skin more susceptible to irritants. Alternate efforts to resolve this problem have turned to matching of refractive indices between the components of the two phases. Water and most water-soluble materials have a relatively low refractive index, I e., about 1.3-1.4, whereas oils and oil soluble materials have refractive indices that range from about 1.4-1.5 for silicone oils, up to about 1.5-1.6 for hydrocarbons. In order to match the two phases, it is necessary to add a further component to the mix to either adjust the water phase index up, or reduce the oil phase index. Most frequently, the additional component is a glycol, usually in fairly high percentages, added to the water phase. Although the resulting product will appear to be clear, it is normally undesirable to use high levels of glycols in cosmetic products, since these compounds are themselves often irritating to the skin of the user. Additionally, since the amount of water that can stably be incorporated into a water-in-oil emulsion is limited, the use of large quantities of glycols in the aqueous phase necessarily reduces the amount of water, and the amount of water soluble actives, that can be used in the emulsion Currently, a frequently used vehicle for transparent products is a nanoemulsion. A nanoemulsion is defined as an oil-m-water emulsion in which the size of the dispersed oil droplets is less than 100 nm. Unlike microemulsions, these are true emulsions that ordinarily achieve the small sized oil droplets by processing the components under high pressure. Nanoemulsions provide an elegant, translucent or transparent vehicle that can be used for a variety of different product types. However, the nanoemulsion is a system in very delicate balance, subject to disruption if the wrong component is added, and not ordinarily capable of taking on too much oil. In addition, the known nanoemulsion systems may rely on the presence of relatively high levels of emulsifiers that are considered irritating, such as ethoxylated fatty ethers and esters. A truly desirable nanoemulsion should retain its transparency or translucency, be able to accommodate a reasonable amount of additives, such as fragrance or actives, while remaining stable, and utilize a low level of non-imtatmg emulsifiers, so as to remain mild and gentle on the skin of the user. The present invention provides such a nanoemulsion.
Summary of the Invention
The present invention relates to stable oil-in-water nanoemulsions comprising as its principle emulsifier a ternary system of surfactants comprising a cationic, anionic and bridging surfactant. The system is believed to provide a unique complex which, even when used at low levels, in combination with standard emulsion components, yields an attractive, translucent or transparent product that has a variety of possible uses. In a preferred embodiment, the components of the ternary system are used in a molar ratio of approximately 1: >1:<1 anionic: bridging: cationic, preferably with a range of up from about 1 : 1 :0.1 up to about 1 :3: 1, and also preferably with an overall approximately neutral charge.
Detailed Description of the Invention The oil- in- water nanoemulsions of the invention are prepared in much the same way as are other nanoemulsions. The aqueous phase may be any cosmetically acceptable water based material, such as deionized water, or a floral water. The oil phase may be any cosmetically or pharmaceutically acceptable oil, such an oil being defined for the present purpose as any pharmaceutically or cosmetically acceptable material which is substantially insoluble in water. As the oils can perform different functions in the composition, the specific choice is dependent on the purpose for which it is intended. The oils may be volatile or non-volatile, or a mixture of both. For example, suitable volatile oils include, but are not limited to, both cyclic and linear sihcones, such as octamethylcyclotetrasiloxane and decamethylcyclopentasiloxane; or straight or branched chain hydrocarbons having from 8-20 carbon atoms, such as decane, dodecane, tridecane, tetradecane, and C8-20 isoparaffins. Non-volatile oils include, but are not limited to, vegetable oils, such as coconut oil, jojoba oil, sunflower oil, palm oil, soybean oil; carboxylic acid esters such as isostearyl neopentanoate, cetyl octanoate, cetyl πcinoleate, octyl palmitate, dioctyl malate, coco-dicaprylate/caprate, decyl isostearate, myπstyl myπstate; animal oils such as lanolm and lanolin derivatives, tallow, mink oil or cholesterol; glyceryl esters, such as glyceryl stearate, glyceryl dioleate, glyceryl distearate, glyceryl lmoleate, glyceryl myπstate; non-volatile sihcones, such as dimethicone, dimethiconol, dimethicone copolyol, phenyl trimethicone, methicone, simethicone; and nonvolatile hydrocarbons, such as lsoparaffms, squalane, or petrolatum.
Water ordinarily will constitute from about 40-70% of the total emulsion, preferably about 50- 65%, while the oil is ordinarily about 5-30% and preferably about 10-20% of the emulsion as a whole The ternary surfactant used is ordinarily added to the phase in which it is most compatible, using heat if necessary to accomplish better solubility or dispersibility, along with any active components which may be desired in the emulsion, and all components mixed together at low pressure. The mixture is then subjected to high pressure mixing. By "high pressure" in the present context is meant a pressure of at least about 10,000 psi to about 20,000 psi; preferably about 11-17,000 psi. It is preferred that the emulsion is subjected to at least two passes, more preferably at least three passes under high pressure. There is no upper limit to the number of passes, but there appears to be no major improvement to be achieved after about seven passes. The preferred equipment is a microfluidizer, such as is available from Microfluidics. However, other suitable high pressure equipment is sold under the brand names Niro Soavi and Rannie. The particle size distribution is normally narrow, and very small, less than lOOnm, preferably with an average size of about 30-50 nm.
A crucial element of the nanoemulsion is the ternary surfactant system used to emulsify the nanoemulsion. The system comprises three essential elements, namely at least one anionic surfactant, at least one cationic surfactant and at least one bridging surfactant. Systems of this type are available commercially as premade blends from Stepan Company, Northfield Illinois, identified as their C-A-N technology. The component surfactants can be added to the emulsion separately, but more often will be preblended before addition.
There is no restriction on the identity of the cationic or anionic surfactants. However, preferably, they are pharmaceutically or cosmetically acceptable surfactants. As a general rule, examples of such surfactants can be readily found, among other sources, in McCutcheon's Detergents and Emulsifiers, M.C. Publishing Company, North American Edition, 2000. The cationic surfactant can be selected from among fatty amine salts, fatty diamine salts, polyamme salts, quaternary ammonium salts, or polyoxyethylenated fatty amine salts, or combinations thereof, with anions being selected from, among others, halogen, sulfate, methosulfate, ethosulfate, tosylate, acetate, phosphate, nitrate, sulfonate, and carboxylate. In particular, the quaternary ammonium salts include mono-long chain alkyl-tri-short chain alkyl ammonium hahdes, wherein the long chain alkyl group has from about 8 to about 22 carbon atoms, and is derived from long chain fatty acids, and the short chain alkyl groups can be the same or different but preferably independently ethyl or methyl. Examples of useful quaternary surfactants include, but are not limited to, cetyl trimethyl ammonium chloride, lauryl tπmethyl ammonium chloride, cocamidopropyl PG-dimonium chloride phosphate, cetπmonium bromide, cetπmonium chloride, hydroxycetyl hydroxyethyl dimonium chloride, quaternium 52, PPG- 40 diethylmomum chloride, dicocodimomum chloride, behentrimonium chloride, quaternιum-26, quaternιum-60, isostearyl ethylimidazolmium ethosulfate, and dihydroxypropyl PEG-5 hneoleammonium chloride.
Useful salts of primary, secondary, and tertiary fatty amines include those having substituted or unsubstituted alkyl groups having from about 12 to about 22 carbon atoms. Suitable salts include the halogen, acetate, phosphate, nitrate, citrate, lactate, and alkyl sulfate salts. Amine salts derived from amine, such as stearamido propyl dimethyl amine, diethyl ammo ethyl stearamide, dimethyl stearamine, dimethyl soyamine, soyamine, myπstyl amine, tridecyl amine, ethyl stearylamme, N- tallow propane diamine, dihydroxy ethyl stearylamme, and arachidylbehenylamine, stearylamme hydrogen chloride, soyamine chloride, stearylamme formate, N-tallow propane diamine dichlonde and stearamidopropyl dimethylamine citrate Other examples of useful quaternary ammonium compounds and amine salt compounds include lmidazohnes, lmadazolmiums and pyπdmiums, wherein the compound has at least one nonionic hydrophile containing radical, such as 2-heptadecyl-4.5-dιhydro- 1 H-imidazol- 1 -ethanol, 4,5 -dihydro- 1 -(2-hydroxyethyl)-2-ιsoheptadecyl- 1 -phenylmethylimidazohum chloride, and l-[2-oxo-2] [[2-[(l-oxoctadecyl)oxy]ethyl]amιno]ethyl]pyπdιnιum chloride.
Anionic surfactants used in the present system are not limited in their nature, again however, preferably being pharmaceutically or cosmetically acceptable. The anionic surfactants include, but are not limited to, sulfates, such as linear and branched primary and secondary alkyl sulfates, alkyl ethoxysulfates, alkyl ether sulfates, fatty oleyl glycerol sulfates, alkyl phenol ethyoxylated sulfates, alkyl phenol ethylene oxide ether sulfates, C5-C17 acyl-N-(Cl-C4 alkyl) and -N-(C1-C2 hydroxyalkyl)glucamιne sulfates, and sulfates of alkylpolysacchaπdes such as the sulfates of alkyl polyglucoside.; sulfonates such as salts of C5-C20 linear alkylbenzene sulfonates, alkyl ester sulfonates, C6-C22 primary or secondary alkane sulfonates, C6-C24 olefin sulfonates, alkyl glycerol sulfonates, fatty acyl glycerol sulfonates, fatty oleyl glycerol sulfonates, and C8-C18 alkyl sulfonates and alpha sulfonated C1-C6 alkyl esters of a fatty acid having an average of from about 11 to about 16 carbon atoms; carboxylates, such as alkyl ethoxy carboxylates, alkyl polyethoxy polycarboxylate surfactants, and their soaps, especially secondary soaps; a sulfosucc ate such as C8-22 sulfosuccinates; a sarcosinate, such as an alkali metal sarcosmate; or a sulfoacetate, such as C12-C20 alkyl sulfoacetates, for example, lauryl and myπstyl sulfoacetate in the form of their sodium salts. A further useful anionic surfactant is the material known as surfactm, a naturally occurring product produced by fermentation of certain strains of Bacillus subtihs, and is commercially available from Showa Denko, KK, Japan. Preferred anionic surfactants, particularly for cosmetic purposes, are alkylaryl sulfonates, alkylaryl sulfonic acids, carboxylated alcohols, carboxylic acids, diphenyl sulfonate derivatives, ethoxylated fatty acids, fluorocarbon-based surfactants, lsethionates, hgnm and derivatives, olefin sulfonates, phosphate esters, phosphorus organic derivatives, polysacchaπdes, acrylic acids, and acrylamides, protein based surfactants, sarcosme, sulfates and sulfomcs of oils and fatty esters, sulfates and sulfomcs of ethoxylated alkylphenols, sulfates of alcohols, sulfates of ethoxylated alcohols, sulfosuccinates, and taurates. Particularly preferred for their mildness are glutamates, succmates, taurates, and lsethionates.
The bridging surfactants used in the present invention include semi-polar nonionic surfactants, ethoxamide surfactants, and amphoteric surfactants. The presence of opposite polar or semi-polar charges on a surfactant molecule is key to the bridging requirement for the ternary system. Semi-polar nonionic surfactants include, but are not limited to, water soluble amine oxides, and water soluble sulfoxides, having at least one CIO- 18 alkyl moiety, and at least one moiety selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1-3 carbon atoms, or amine- oxide derived surfactants. Ethoxamides useful in the invention are ethoxylated alkanol amides or polyethylene glycol amides such as PEG-3 cocoamide or PEG-6 lauramide.
Preferably, the bridging surfactant is an amphoteric surfactant. Preferred are pharmaceutically or cosmetically acceptable amphoteπcs. Example of useful amphoteπcs include, but are not limited to, alkyl glycinates, propionates, lmidazolmes, amphoalkylsulfonates, N-alkylammopropionic acids, N- alkylimmodipropionic acids, lmidazohne carboxylates, N-alkybetaines, amido propyl betames, sarcosmates, cocoamphocarboxyglycinates, amine oxides, sulfobetaines, or sultames. Particularly preferred, especially for cosmetic use, are the betame amphoteric surfactants, particularly amidopropyl betames.
The choice of components for the system is preferably based on a total HLB for the system of about 5-12, and preferably an overall substantially neutral charge. The preferred combination of surfactants for cosmetic use is a glutamate as anionic surfactant, a quaternary ammonium salt as cationic surfactant, and an amidopropyl betaine as amphoteric. This combination is especially mild when applied to the skin and hair. It has been unexpectedly discovered that, although an eqmmolar ratio of surfactant components can be used, i.e., in a 1 : 1 : 1 ratio, for purposes of use in emulsifying a nanoemulsion, the ternary system is, in many embodiments, preferably used in a molar ratio of approximately 1 anionic: >1 bridging: 1 cationic. Alternately, however, when the bridging surfactant is a semi -polar nonionic surfactant, the proportion of cationic surfactant can be reduced to <1, in a range down to a level of about 0.1 up to less than 1, preferably in a range of from about 0.25 to about 0.5. Generally, the ternary combination, in the stated molar ratios, will be added to the composition in an amount ranging from about 0.5-5 % total surfactant, preferably 1-3% total surfactant, by weight of the total composition. Ordinarily, the combination will be added as a preblend, but each component can also be added separately to the composition. Interestingly, it has also been found that, although each component is itself recognized as a surfactant, none of the components alone is adequate to achieve a stable nanoemulsion, all three must be used together.
Although the ternary system can be used alone, it is sometimes desirable to supplement the three main components with an additional small quantity of a secondary surfactant, preferably with an HLB of between about 3-5. Preferably, the secondary surfactant is a glyceryl fatty ester and derivatives thereof, such as glyceryl monostearate, glyceryl monolaurate, glyceryl monooleate, PEG 100 stearate, glycerol mono/distearate, polyglyceryl-2-stearate, fatty acid polyglycerol esters, hexaglycerol distearate, propylene glycol monolaurate and propylene glycol stearate. Other types of suitable secondary surfactants include hydroxylated lanolin, lanolin alcohol, ethoxylated castor oil, sorbitan monotallate, sorbitan monooleate, sorbitan sesquioleate, ethoxylated fatty amines, lecithin, oleth-2, palmitic/steaπc acid esters, distilled monoglyceπdes, block copolymers of ethylene oxide and propylene oxide, cholesterol, dimethicone copolyol, and ethoxylated triglyceπdes, Normally, the secondary surfactant will be used in an amount of from about 0 5-5%, preferably about 0 5-2%, by weight of the total composition
It also may be desirable to provide additional components, such as solubihzers, to the composition to enhance the clarity of the final nanoemulsion. Preferred for this purpose are alcohols, for example, short chain monohydric alcohols, such as ethanol or isopropanol, and/or polyhydπc alcohols, such as butylene or propylene glycol, isopentyl diol, or amido-diols. The presence of a monohydric alcohol is strongly preferred, in an amount of from about greater than zero, to about 30%, preferably about 5-25%, and most preferred, at least about 10%, by weight of the composition. Polyhydπc alcohols, if used, will be used in an amount of from about greater than zero to about 10%, preferably about 1-5%, by weight of the total composition.
Depending upon the intended use of the final product, it is also possible to provide the compositions with active agents or additives appropriate to the intended use. The preferred use of the compositions are as pharmaceutical or cosmetic vehicles, for application to the skin or hair. The nanoemulsions of the invention, in part because of the presence of the cationic surfactant, provide a very efficient delivery system for a wide variety of active components. The formulations are highly substantive to skin and hair, the emulsifying system exhibits a substantial degree of water resistance, and also potentially contributes to the preservation of the formulation as a whole . Examples of additional components that may be useful include, but are not limited to, agents for the eradication of age spots, keratoses and wrinkles, analgesics, anesthetics, anti-acne agents, antibacteπals, antiyeast agents, antifungal agents, antiviral agents, antidandruff agents, antidermatitis agents, antipruπtic agents, antiemetics, antimotion sickness agents, anti-inflammatory agents, antihyperkeratolytic agents, anti-dry skin agents, antiperspirants, antipsonatic agents, antiseborrheic agents, hair conditioners and hair treatment agents, antiaging agents, antiwrmkle agents, antiasthmatic agents and bronchodilators, sunscreen agents, antihistamine agents, skin lightening agents, depigmenting agents, vitamins, corticosteroids, self-tanning agents, hormones, retmoids such as retinoic acid and retinol, topical cardiovascular agents, clotnmazole, ketoconazole, miconozole, gπseofulvm, hydroxyzme, diphenhydramine, pramoxme, hdocaine, procaine, mepivacaine, monobenzone, erythromycm, tetracycline, clindamycin, meclocyline, hydroquinone, minocychne, naproxen, ibuprofen, theophylline, cromolyn, albuterol, topical steroids such as hydrocortisone, hydrocortisone 21 -acetate, hydrocortisone 17-valerate, and hydrocortisone 17-butyrate, betamethasone valerate, betamethasone dipropπonate, tnamcinolone acetonide, fluocinonide, clobetasol, propnonate, benzoyl peroxide, crotamiton, propranolol, promethazine, vitamin A palrmtate, vitamin E acetate and mixtures thereof. It is also possible to add non-therapeutic or non-active agents, such as emollients, flavors, colorants, fragrances, gellants, thickeners, sunscreens, and the like, which enhance the ultimate use of the product, particularly for topical cosmetic or pharmaceutical purposes, and provided care is taken to avoid choosing components that will interfere with the clarity of the product. The final product can take the form of a milk, cream, lotion, gel, serum, or liquid spray, among others. A particularly interesting use of the nanoemulsions of the invention is in the preparation of sunscreen formulations. It has been difficult to achieve a translucent product with the addition of sunscreens to other types of nanoemulsions. However, with the present nanoemulsion, the addition of sunscreen does not destroy the clarity of the product, thereby yielding a translucent sunscreen product which has been heretofore difficult to achieve. The nanoemulsions of the invention may therefore incorporate one or more sunscreen agents, such as benzophenones, avobenzone, cmnamates, sahcylates, and the like.
The invention is further illustrated by the following non-hmitmg examples.
EXAMPLES Example 1
A nanoemulsion of the following composition is prepared:
Material Wt. %
Phase I Purified water 59.40
Glycerin 6.00
Surfactant blend* 5.50
Isopentyldiol 2.00
Tπethanolamine 0.10
Phase II Squalane 5.50
Cetyl alcohol 0.50
Ethanol 15.00
Phase III
Cyclomethicone 6.00
*contams: 19% sodium stearoyl glutamate, 7.5% cocamidopropyl PG-dimomum chloride phosphate, and 9% C16-C18 amidopropyl betaine, QS water to 100%.
The components above are combined as follows: The water phase components (Phase I) are heated to 65°C, and the oil phase components (Phase II) are heated to 75°C When both phases have reached the proper temperature, the oil phase is added to the water phase under a Silverson homogenizer at about 5000-6000 rpm. This batch is then passed through a microfluidizer once, at a pressure of about 13,000-17,000 psi. The Phase III components are added under the Silverson homogenizer at about 5000-6000 rpm, and then the entire product is passed through a microfluidizer three more times. The resulting product is a translucent nanoemulsion which is stable for at least 4 weeks at 50°C.
Additional nanoemulsions are prepared using the following surfactant blends(all QS water to 100%):
(a) 20% sodium stearoyl glutamate, 8% cocamidopropyl PG-dimonium chloride phosphate, and 8% lauramidopropyl betaine
(b) 11.5% sodium stearoyl glutamate, 5% cocamidopropyl PG-dimonium chloride phosphate, 5% C16,18 amidopropyl betaine, 7% glyceryl monophosphate, 6% glyceryl stearate/PEG-100 stearate (c) 9.5% sodium lauroyl sarcosinate, 5 5% cocamidopropyl PG-dimonium chloride phosphate,
7% C16.18 amidopropyl betaine, 7%glyceryl monostearate, 6% glyceryl stearate/PEG-100 stearate
(d) 19% sodium stearoyl glutamate, 8% cocamidopropyl PG-dimonium chloride phosphate, 9% C16,18 amidopropyl betaine, 12% glyceryl monostearate
(e) 13% sodium stearoyl glutamate, 5% cocamidopropyl PG-dimonium chloride phosphate, 6% C16,18 amidopropyl betaine, 8% glyceryl monostearate, 3% cyclodextnn
Example 2
A sunscreen-containing nanoemulsion is prepared as follows:
Material Wt. %
Phase I Purified water 53.90
Glycerin 6.00
Tπethanolamine 0.10
Surfactant blend* 5.00
Phase II
Jojoba seed oil 6.00
Cetyl alcohol 0.50
Phase III
Avobenzone 1.50
Octyl methoxycinnamate 6.00
Phase IV Ethanol 15.00
Phase V
Cyclomethicone 6.00
*Contams 24% isostearamidopropyl dimethylamine/isostearic acid, 20% sodium stearoyl glutamate, 10% glyceryl stearate, 10% glyceryl stearate, 3% steaπc acid, QS water to 100%.
The formula described above is prepared as follows: The water phase and surfactant blend are heated to 65°C. The oil phase is heated to 75°C, and homogenized into the water. The mixture is passed through the microfluidizer once, and cooled to 30°C Phases III and IV are added in sequence, then phase V is added. The resulting mixture is then passed through the microfluidizer as described in Example 1.

Claims

What we claim is:
1. An oil-in-water nanoemulsion comprising as primary surfactant a ternary surfactant system containing at least one of each of a cationic surfactant, an anionic surfactant, and a bridging surfactant.
2 The nanoemulsion of claim 1 in which the surfactants are provided in a molar ratio of approximately 1 anionic. >1 bridging- <1 cationic, and in which the system has an overall substantially neutral charge.
3. The nanoemulsion of claim 1 in which the cationic surfactant is selected from the group consisting of fatty amine salts, fatty diamine salts, polyamme salts, quaternary or diquaternary ammonium salts, polyoxyethylenated fatty amme salts, and combinations thereof.
4. The nanoemulsion of claim 1 in which the anionic surfactant is selected from the group consisting of glutamates, succinates, taurates, and lsethionates.
5. The nanoemulsion of claim 1 in which the bridging surfactant is selected from the group consisting of include semi-polar nonionic surfactants, ethoxamide surfactants, and amphoteric surfactants.
6. The nanoemulsion of claim 5 in which the semi-polar nonionic surfactant is selected from the group consisting of water soluble amine oxides, water soluble sulfoxides having at least one CIO- 18 alkyl moiety, and at least one moiety selected from the group consisting of alkyl groups and hydroxyalkyl groups containing from about 1-3 carbon atoms, and amme-oxide derived surfactants.
7. The nanoemulsion of claim 5 in which the ethoxamide is selected from the group consisting of ethoxylated alkanol amides and polyethylene glycol amides.
8. The nanoemulsion of claim 5 in which the amphoteric surfactant is selected from the group consisting of alkyl glycinates, propionates, lmidazohnes, amphoalkylsulfonates, N- alkylaminopropiomc acids, N-alkyhminodipropionic acids, imidazohne carboxylates, N-alkylbetaines, amido propyl betames, sarcosinates, cocoamphocarboxyglycinates, amme oxides, sulfobetaines, and sultaines.
9. The nanoemulsion of claim 5 in which the surfactant is an amphoteric surfactant.
10. The nanoemulsion of claim 1 which comprises a glutamate as an anionic surfactant, an amidopropyl betaine as a bridging surfactant, and a quaternary or diquatemary ammonium salt as a cationic surfactant, in a molar ratio of approximately 1 ">1 :<1
11. The nanoemulsion of claim 1 which also comprises a secondary surfactant selected from the group consisting of surfactants having an HLB of about 3-5.
12. The nanoemulsion of claim 11 in which the secondary surfactant is a glycerol fatty acid ester or derivative thereof.
13 The nanoemulsion of claim 1 which also comprises a solubihzer selected from the group consisting of monohydric alcohols, polyhydnc alcohols, or a combination thereof.
14. The nanoemulsion of claim 13 which comprises a monohydric alcohol in an amount of at least about 10%) by weight.
15. The nanoemulsion of claim 1 which also comprises a sunscreen.
16. An oil-in-water nanoemulsion comprising as primary surfactant a ternary surfactant system containing at least one of each of an anionic surfactant, a bridging surfactant and cationic surfactant in a ratio of about 1 :>1 :<1, wherein the anionic surfactant is selected from the group consisting of glutamates, succinates, taurates, lsethionates, and combinations thereof; the bridging surfactant is an amphoteric surfactant selected from the group consisting of alkyl glycmates, propionates, imidazohnes, amphoalkylsulfonates, N-alkylammopropiomc acids, N-alkyhminodipropionic acids, imidazohne carboxylates, N-alkylbetames, amido propyl betames, sarcosinates, cocoamphocarboxyglycinates, amine oxides, sulfobetaines, sultaines and combinations thereof; and the cationic surfactant is selected from the group consisting of fatty amme salts, fatty diamine salts, polyamine salts, quaternary or diquatemary ammonium salts, polyoxyethylenated fatty amine salts, and combinations thereof; wherein the ternary system has an overall substantially neutral charge.
17. The nanoemulsion of claim 16 in which the surfactants of the ternary system are present in a combined amount of from about 0.5 to about 5%.
18 The nanoemulsion of claim 16 which comprises a secondary surfactant having an HLB of from about 3-5, in an amount of from about 0.5% to about 5%.
19. The nanoemulsion of claim 18 in which the secondary surfactant is a glycerol fatty acid ester or derivative thereof.
20. The nanoemulsion of claim 16 which comprises a solubihzer selected from the group consisting of short chain monohydric alcohols, short chain polyhydnc alcohols, amido-diols, and combinations thereof.
21. The nanoemulsion of claim 20 which comprises as solubihzer at least one short chain monohydric alcohol in an amount of at least about 10%.
PCT/US2002/009630 2001-03-30 2002-03-29 Novel nanoemulsions WO2002080864A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US10/471,044 US20040115159A1 (en) 2002-03-29 2002-03-29 Novel nanoemulsions
EP02728600A EP1377255A4 (en) 2001-03-30 2002-03-29 Novel nanoemulsions
AU2002258644A AU2002258644B2 (en) 2001-03-30 2002-03-29 Novel nanoemulsions
JP2002578903A JP4444565B2 (en) 2001-03-30 2002-03-29 New nanoemulsion
CA002442660A CA2442660A1 (en) 2001-03-30 2002-03-29 Novel nanoemulsions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28070001P 2001-03-30 2001-03-30
US60/280,700 2001-03-30

Publications (1)

Publication Number Publication Date
WO2002080864A1 true WO2002080864A1 (en) 2002-10-17

Family

ID=23074227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009630 WO2002080864A1 (en) 2001-03-30 2002-03-29 Novel nanoemulsions

Country Status (5)

Country Link
EP (1) EP1377255A4 (en)
JP (1) JP4444565B2 (en)
AU (1) AU2002258644B2 (en)
CA (1) CA2442660A1 (en)
WO (1) WO2002080864A1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1525875A1 (en) * 2003-10-23 2005-04-27 L'oreal Stable pH cosmetic or dermatological O/W emulsion
FR2869802A1 (en) * 2004-05-04 2005-11-11 I N E A S L COSMETIC AND / OR DERMATOLOGICAL COMPOSITION HAVING HYPOALERGENIC PRESERVATORY PROPERTIES
EP1702607A1 (en) * 2004-01-06 2006-09-20 Shiseido Company, Ltd. Monophase microemulsion composition, o/w ultrafine emulsion external formulation and process for producing the same
EP1813251A2 (en) * 2006-01-30 2007-08-01 Goldschmidt GmbH Cold producible emulsions with low viscosity and long term stability
WO2007117720A2 (en) * 2006-04-05 2007-10-18 Elc Management Llc Hydrophobic agents stably dispersed in oil-in-water emulsions
EP2111335A1 (en) * 2007-01-19 2009-10-28 The Regents Of The University Of California Elastic vitrification of emulsions by droplet rupturing
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
WO2010083368A3 (en) * 2009-01-16 2011-08-11 Neocutis Sa Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
EP2410040A1 (en) * 2010-07-19 2012-01-25 Rovcal, Inc. Universal aqueous cleaning solution for electric shavers
WO2012062519A1 (en) * 2010-11-10 2012-05-18 Evonik Goldschmidt Gmbh Composition comprising mixtures of isostearamide, glycerol ester and water
WO2012055583A3 (en) * 2010-10-28 2013-01-24 Henkel Ag & Co. Kgaa Hair treatment products containing 3-methyl-1,3-butanediol and anionic surfactant(s)
WO2012009778A3 (en) * 2010-07-22 2013-02-07 Evidence Soluções Farmacêuticas Ltda Epp A stable topical composition and a process for producing a stable topical composition
WO2012055582A3 (en) * 2010-10-28 2013-03-07 1/Henkel Ag & Co. Kgaa Hair treatment products containing 3-methyl-1,3-butanediol and amphoteric surfactant(s)
US8703164B2 (en) 2003-06-04 2014-04-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US9486409B2 (en) 2006-12-01 2016-11-08 Anterios, Inc. Peptide nanoparticles and uses therefor
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
US9724299B2 (en) 2006-12-01 2017-08-08 Anterios, Inc. Amphiphilic entity nanoparticles
WO2017182264A1 (en) 2016-04-21 2017-10-26 Unilever Plc Novel nanoemulsions comprising fatty acid and n-acyl derivatives of amino acid salt
US9801842B2 (en) 2007-05-02 2017-10-31 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US10016364B2 (en) 2005-07-18 2018-07-10 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US10016451B2 (en) 2007-05-31 2018-07-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
WO2018192761A1 (en) 2017-04-20 2018-10-25 Unilever Plc Nanoemulsions comprising sulfoalkyl ester and/or amide of fatty acids in aqueous phase
WO2019072507A1 (en) * 2017-10-10 2019-04-18 Unilever Plc Nanoemulsions with neutralized fatty acid and a method producing the same
WO2019096382A1 (en) * 2017-11-16 2019-05-23 Beiersdorf Ag Clear hydro-alcoholic roll-on formulation
DE102019211844A1 (en) * 2019-08-07 2021-02-11 Beiersdorf Ag Cosmetic nanoemulsion
US11026869B2 (en) 2016-04-21 2021-06-08 Conopco, Inc. Process for producing small droplet emulsions at low pressure
CN114181718A (en) * 2021-12-09 2022-03-15 中石化石油工程技术服务有限公司 Bola type surfactant, nano emulsion and application
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
US11807867B2 (en) 2020-02-21 2023-11-07 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100849537B1 (en) * 2007-07-04 2008-07-31 유효경 Nano-emulsion composition of coenzyme q10
CN105451871A (en) * 2013-08-12 2016-03-30 株式会社钟化 Surfactant composition
EP3510161A4 (en) 2016-08-23 2020-04-22 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
KR101837433B1 (en) * 2017-05-26 2018-03-12 주식회사 스타프랜즈 Nanoemulsion, preparing method thereof, and cosmetic composition containing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256407A (en) * 1990-12-13 1993-10-26 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Hair styling composition
US5911978A (en) * 1996-10-31 1999-06-15 Helene Curtis, Inc. Hair treatment composition
US5972356A (en) * 1997-11-05 1999-10-26 The Procter & Gamble Company Personal care compositions
US6087317A (en) * 1998-12-10 2000-07-11 Dow Corning Corporation Particle size stable silicone emulsions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019507A1 (en) * 1999-09-17 2001-03-22 Stepan Company Ternary surfactant blends comprising cationic, anionic, and bridging surfactants and methods of preparing same
US6528070B1 (en) * 2000-09-15 2003-03-04 Stepan Company Emulsion comprising a ternary surfactant blend of cationic, anionic, and bridging surfactants, oil and water, and methods of preparing same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256407A (en) * 1990-12-13 1993-10-26 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Hair styling composition
US5911978A (en) * 1996-10-31 1999-06-15 Helene Curtis, Inc. Hair treatment composition
US5972356A (en) * 1997-11-05 1999-10-26 The Procter & Gamble Company Personal care compositions
US6087317A (en) * 1998-12-10 2000-07-11 Dow Corning Corporation Particle size stable silicone emulsions

Cited By (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US8771731B2 (en) 1999-04-28 2014-07-08 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US9131680B2 (en) 2003-06-04 2015-09-15 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US8703164B2 (en) 2003-06-04 2014-04-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
EP1525875A1 (en) * 2003-10-23 2005-04-27 L'oreal Stable pH cosmetic or dermatological O/W emulsion
FR2861295A1 (en) * 2003-10-23 2005-04-29 Oreal COSMETIC OR DERMATOLOGICAL H / E EMULSION OF STABLE PH
EP1702607A1 (en) * 2004-01-06 2006-09-20 Shiseido Company, Ltd. Monophase microemulsion composition, o/w ultrafine emulsion external formulation and process for producing the same
EP1702607A4 (en) * 2004-01-06 2012-07-04 Shiseido Co Ltd Monophase microemulsion composition, o/w ultrafine emulsion external formulation and process for producing the same
WO2005107696A1 (en) * 2004-05-04 2005-11-17 Cosmetic Laboratory Concepts Clc Cosmetic and/or dermatological composition exhibiting preservative hypoallergenic properties
FR2869802A1 (en) * 2004-05-04 2005-11-11 I N E A S L COSMETIC AND / OR DERMATOLOGICAL COMPOSITION HAVING HYPOALERGENIC PRESERVATORY PROPERTIES
US10016364B2 (en) 2005-07-18 2018-07-10 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US10576034B2 (en) 2005-12-01 2020-03-03 University Of Massachusetts Lowell Botulinum nanoemulsions
US10532019B2 (en) 2005-12-01 2020-01-14 University Of Massachusetts Lowell Botulinum nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP1813251A2 (en) * 2006-01-30 2007-08-01 Goldschmidt GmbH Cold producible emulsions with low viscosity and long term stability
EP1813251A3 (en) * 2006-01-30 2010-06-23 Evonik Goldschmidt GmbH Cold producible emulsions with low viscosity and long term stability
US8795692B2 (en) 2006-01-30 2014-08-05 Evonik Degussa Gmbh Cold-preparable, low-viscosity and prolonged-stability cosmetic emulsions
WO2007117720A3 (en) * 2006-04-05 2007-11-29 Elc Man Llc Hydrophobic agents stably dispersed in oil-in-water emulsions
WO2007117720A2 (en) * 2006-04-05 2007-10-18 Elc Management Llc Hydrophobic agents stably dispersed in oil-in-water emulsions
US8652493B2 (en) 2006-04-05 2014-02-18 Elc Management, Llc Hydrophobic agents stably dispersed in oil-in-water emulsions
US9486409B2 (en) 2006-12-01 2016-11-08 Anterios, Inc. Peptide nanoparticles and uses therefor
US9724299B2 (en) 2006-12-01 2017-08-08 Anterios, Inc. Amphiphilic entity nanoparticles
US10905637B2 (en) 2006-12-01 2021-02-02 Anterios, Inc. Peptide nanoparticles and uses therefor
US10285941B2 (en) 2006-12-01 2019-05-14 Anterios, Inc. Amphiphilic entity nanoparticles
US10758485B2 (en) 2006-12-01 2020-09-01 Anterios, Inc. Amphiphilic entity nanoparticles
EP2111335A1 (en) * 2007-01-19 2009-10-28 The Regents Of The University Of California Elastic vitrification of emulsions by droplet rupturing
EP2111335A4 (en) * 2007-01-19 2012-08-15 Univ California Elastic vitrification of emulsions by droplet rupturing
US9801842B2 (en) 2007-05-02 2017-10-31 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US10016451B2 (en) 2007-05-31 2018-07-10 Anterios, Inc. Nucleic acid nanoparticles and uses therefor
CN102281863A (en) * 2009-01-16 2011-12-14 新科蒂斯公司 Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
US9326930B2 (en) 2009-01-16 2016-05-03 Neocutis S.A. Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
WO2010083368A3 (en) * 2009-01-16 2011-08-11 Neocutis Sa Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
EP2410040A1 (en) * 2010-07-19 2012-01-25 Rovcal, Inc. Universal aqueous cleaning solution for electric shavers
US8119584B2 (en) 2010-07-19 2012-02-21 Rovcal, Inc. Universal aqueous cleaning solution for electric shavers
WO2012009778A3 (en) * 2010-07-22 2013-02-07 Evidence Soluções Farmacêuticas Ltda Epp A stable topical composition and a process for producing a stable topical composition
WO2012055582A3 (en) * 2010-10-28 2013-03-07 1/Henkel Ag & Co. Kgaa Hair treatment products containing 3-methyl-1,3-butanediol and amphoteric surfactant(s)
WO2012055583A3 (en) * 2010-10-28 2013-01-24 Henkel Ag & Co. Kgaa Hair treatment products containing 3-methyl-1,3-butanediol and anionic surfactant(s)
US9616007B2 (en) 2010-11-10 2017-04-11 Evonik Degussa Gmbh Composition comprising mixtures of isostearamide, glycerol ester and water
WO2012062519A1 (en) * 2010-11-10 2012-05-18 Evonik Goldschmidt Gmbh Composition comprising mixtures of isostearamide, glycerol ester and water
CN109069369B (en) * 2016-04-21 2022-01-11 联合利华知识产权控股有限公司 Novel nanoemulsions comprising N-acyl derivatives of fatty acids and amino acid salts
US11744783B2 (en) 2016-04-21 2023-09-05 Conopco, Inc. Nanoemulsions comprising fatty acid and n-acyl derivatives of amino acid salt
CN109069369A (en) * 2016-04-21 2018-12-21 荷兰联合利华有限公司 The novel nano lotion of N- acyl derivative comprising fatty acid and amino-acid salt
WO2017182264A1 (en) 2016-04-21 2017-10-26 Unilever Plc Novel nanoemulsions comprising fatty acid and n-acyl derivatives of amino acid salt
EA037016B1 (en) * 2016-04-21 2021-01-27 Юнилевер Н.В. Personal cleansing nanoemulsion compositions and process for preparing same
US11026869B2 (en) 2016-04-21 2021-06-08 Conopco, Inc. Process for producing small droplet emulsions at low pressure
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2018192761A1 (en) 2017-04-20 2018-10-25 Unilever Plc Nanoemulsions comprising sulfoalkyl ester and/or amide of fatty acids in aqueous phase
US11234908B2 (en) 2017-04-20 2022-02-01 Conopco, Inc. Nanoemulsions comprising sulfoalkyl ester and/or amide of fatty acids in aqueous phase
CN111182883A (en) * 2017-10-10 2020-05-19 荷兰联合利华有限公司 Nanoemulsion with neutralized fatty acid and method for producing same
US11219581B2 (en) 2017-10-10 2022-01-11 Conopco, Inc. Nanoemulsions with neutralized fatty acid and a method producing the same
WO2019072507A1 (en) * 2017-10-10 2019-04-18 Unilever Plc Nanoemulsions with neutralized fatty acid and a method producing the same
WO2019096382A1 (en) * 2017-11-16 2019-05-23 Beiersdorf Ag Clear hydro-alcoholic roll-on formulation
DE102019211844A1 (en) * 2019-08-07 2021-02-11 Beiersdorf Ag Cosmetic nanoemulsion
US11807867B2 (en) 2020-02-21 2023-11-07 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
US12077773B2 (en) 2020-02-21 2024-09-03 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject
CN114181718A (en) * 2021-12-09 2022-03-15 中石化石油工程技术服务有限公司 Bola type surfactant, nano emulsion and application

Also Published As

Publication number Publication date
AU2002258644B2 (en) 2006-12-14
JP4444565B2 (en) 2010-03-31
JP2004532214A (en) 2004-10-21
EP1377255A1 (en) 2004-01-07
CA2442660A1 (en) 2002-10-17
EP1377255A4 (en) 2008-11-19

Similar Documents

Publication Publication Date Title
AU2002258644B2 (en) Novel nanoemulsions
AU2002258644A1 (en) Novel nanoemulsions
US20040115159A1 (en) Novel nanoemulsions
JP4040527B2 (en) Lipid composition and external preparation for skin containing the same
EP1003460B1 (en) Water containing wax-based product
Azeem et al. Emerging role of microemulsions in cosmetics
US5008100A (en) Oil-in-water emulsions containing polyethylene
NZ280600A (en) Water-in-oil-in-water multiple emulsion compositions, for delivery of topically active substance to skin or hair
WO2001062214A1 (en) Gelled aqueous cosmetic compositions
KR20040042876A (en) Water-in-oil emulsion cosmetic composit ion
JPH10513179A (en) Roll-on antiperspirant composition
JP2001187711A (en) Cosmetic
US9526682B2 (en) Fine O/W emulsion
KR102532929B1 (en) Composition for skin cosmetics
KR20180124339A (en) Transparent hair cosmetic composition
JP5189836B2 (en) Oil-containing cosmetic composition
JP2022548683A (en) High oil content gel composition, method of preparation and use thereof
JPH11286418A (en) Oil-in-water type emulsion hair cosmetic
US7252830B2 (en) Moisturizing compositions
JP7309400B2 (en) emulsified cosmetic composition
JP2023152863A (en) Skin cosmetic composition
EP3582746B1 (en) Cosmetic lotion
JP2004352646A (en) Foamy cosmetic with warm feeling stable with time
JP2001019609A (en) Multiphase emulsion-form skin preparation for external use
JP2024076141A (en) Method for producing skin cosmetic

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10471044

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002258644

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002728600

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2442660

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002578903

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002728600

Country of ref document: EP